Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2001
10/17/2001CN1318052A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers
10/17/2001CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/17/2001CN1073080C Process for mfg. mixed anhydrides
10/17/2001CN1072934C Pharmaceutical emulsion
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
10/16/2001US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001US6303635 Thrombolytic drug
10/16/2001US6303627 For therapy of physiological and psychological disorders
10/16/2001US6303625 Triazolopyridines for the treatment of thrombosis disorders
10/16/2001US6303620 Compounds with growth hormone releasing properties
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/11/2001WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074777A1 4-formyl amino-n-methylpiperidine derivatives, the use thereof as stabilisers and organic material stabilised therewith
10/11/2001WO2001074776A1 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
10/11/2001WO2001074762A2 Arylsulfates and their use as enhancers or inhibitors of bioadhesion to surfaces
10/11/2001WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001US20010029258 Partially saturated calcium channel blockers
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/10/2001EP1142887A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1140912A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140842A1 Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates
10/10/2001EP1140841A1 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140833A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
10/10/2001EP1140832A1 Process for preparing arylpiperidine carbinol intermediates and derivatives
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140830A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
10/10/2001EP1140829A1 Contrast media for angiography
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140821A1 Lactams
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140811A1 Novel herbicides
10/10/2001EP1140807A1 Method for preparing nitroxides
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140791A2 Selective cpla 2 inhibitors
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP1140084A1 Novel formulation
10/10/2001EP1140058A1 N-formyl hydroxylamine derivatives as antibacterial agents
10/10/2001EP1140055A1 Use of a 5ht 2a? and 5ht 2a/c? receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316994A Piperidine derivatives
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072662C Phenyl alkyl ketone substituted by cyclic amine and process for preparation thereof
10/09/2001US6300533 Using c-substituted-amino cyclic nitroxides, especially 4-amino-2,2,6,6-tetramethyl-1-piperidinyloxy, to inhibit polymerization of unsaturated monomers
10/09/2001US6300513 Causing n-oxyl compound, n-hydroxy-2,2,6,6-tetramethylpiperidine compound and 2,2,6,6-tetramethylpiperidine compound to co-exist in vinyl compound
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001046144A8 New modulators of dopamine neurotransmission
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001WO2001005764A3 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester
10/04/2001EP1138682A1 Novel water soluble c-ring analogues of 20 (s)-camptothecin
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1138678A2 Process for making N-((4-phenyl) methylphenyl) piperazines
10/04/2001EP1138673A2 Novel carbamates and ureas as modifiers of multi-drug resistance
10/04/2001EP1137647A1 Thiourea inhibitors of herpes viruses
10/04/2001EP1137637A1 N-(2-phenyl-4-piperidinylbutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
10/04/2001EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
10/04/2001EP1137416A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/04/2001EP1137412A2 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
10/04/2001EP0888304B1 Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same by 4-arylo-4-cyanoheptane dicarboxylic acid cyclisation, and use thereof for preparing 3-aryl-3-hydroxyalkylpiperidines
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0815081B1 Piperidinyl-2-alkyl substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation
10/04/2001EP0757673B1 Heterocyclylbenzonitriles
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/03/2001CN1315951A FKBP inhibitors
10/03/2001CN1315945A Nitrate salts of antihypertensive medicines
10/03/2001CN1315873A Prevention/remedies for multiple organ failure
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 380